Abstract:Abstract Proton Bragg peak irradiation has a higher ionizing density than conventional photon irradiation or the entrance of the proton beam profile. Whether targeting the DNA damage response (DDR) could enhance vulnerability to the distinct pattern of damage induced by proton Bragg peak irradiation is currently unknown. Here, we performed genetic or pharmacologic manipulation of key DDR elements and evaluated DNA damage signaling, DNA repair, and tumor control in cell lines and xenografts treated with the same physical dose across a radiotherapy linear energy transfer spectrum. Radiotherapy consisted of 6 MV photons and the entrance beam or Bragg peak of a 76.8 MeV spot scanning proton beam. More complex DNA double-strand breaks (DSB) induced by Bragg peak proton irradiation preferentially underwent resection and engaged homologous recombination (HR) machinery. Unexpectedly, the ataxia-telangiectasia mutated (ATM) inhibitor, AZD0156, but not an inhibitor of ATM and Rad3-related, rendered cells hypersensitive to more densely ionizing proton Bragg peak irradiation. ATM inhibition blocked resection and shunted more DSBs to processing by toxic ligation through nonhomologous end-joining, whereas loss of DNA ligation via XRCC4 or Lig4 knockdown rescued resection and abolished the enhanced Bragg peak cell killing. Proton Bragg peak monotherapy selectively sensitized cell lines and tumor xenografts with inherent HR defects, and the repair defect induced by ATM inhibitor coadministration showed enhanced efficacy in HR-proficient models. In summary, inherent defects in HR or administration of an ATM inhibitor in HR-proficient tumors selectively enhances the relative biological effectiveness of proton Bragg peak irradiation. Significance: Coadministration of an ATM inhibitor rewires DNA repair machinery to render cancer cells uniquely hypersensitive to DNA damage induced by the proton Bragg peak, which is characterized by higher density ionization. See related commentary by Nickoloff, p. 3156

Mechanisms of Increased Risk of Tumorigenesis in Atm and Brca1 Double Heterozygosity

Impaired Skin And Mammary Gland Development And Increased Gamma-Irradiation-Induced Tumorigenesis In Mice Carrying A Mutation Of S1152-Atm Phosphorylation Site In Brca1

Data from Impaired Skin and Mammary Gland Development and Increased γ-Irradiation–Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1

Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Mechanisms for ATM Mediated Downstream Gene BRCA1 and RAD51 in Signaling Pathway of DNA Injury Repair

Supplementary Figures from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Gene-environment Interaction for Polymorphisms in Ataxia Telangiectasia-Mutated Gene and Radiation Exposure in Carcinogenesis: Results from Two Literature-Based Meta-Analyses of 27120 Participants

Radiation-induced Effects of ATM Gene on Expressions of BRCA1 and RAD51 Detected by Laser Scanning Confocal Microscopy

Atm-Chk2-P53 Activation Prevents Tumorigenesis At An Expense Of Organ Homeostasis Upon Brca1 Deficiency

ATM – Chk 2 – p 53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca 1 deficiency

Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.

ATM Expression is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency

Phosphorylation of BRCA1 by ATM Upon Double-Strand Breaks Impacts ATM Function in End-Resection: A Potential Feedback Loop

ATM sequence variants associate with susceptibility to non-small cell lung cancer.

A Targeted Disruption of the Murine Brca1 Gene Causes Γ-Irradiation Hypersensitivity and Genetic Instability

Deficiency of Human BRCA2 Leads to Impaired Homologous Recombination but Maintains Normal Nonhomologous End Joining

Evidence Of Haplotype Insufficiency In Human Cells Containing A Germline Mutation In Brca1 Or Brca2

Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice

The Atm-P53 Pathway Suppresses Aneuploidy-Induced Tumorigenesis

Implication of Ataxia-Telangiectasia-mutated Kinase in Epithelium-Mesenchyme Transition

Nonhomologous End-Joining of Ionizing Radiation-Induced DNA Double-Stranded Breaks in Human Tumor Cells Deficient in BRCA1 or BRCA2.